This is a summary of the European public assessment report (EPAR) for Spedra. It explains how the European Medicines Agency assessed the medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Spedra. For practical information about using Spedra, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
### Therapeutic indication Treatment of erectile dysfunction in adult men. In order for Spedra to be effective, sexual stimulation is required.
Therapeutic Area (MeSH)
ATC Code
G04BE10
ATC Item
avanafil
Pharmacotherapeutic Group
Drugs used in erectile dysfunction
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| avanafil | N/A | 阿伐那非 |
EMA Name
Spedra
Medicine Name
Spedra
Aliases
N/ANo risk management plan link.
